Bank of Nova Scotia
BMY icon

Bank of Nova Scotia’s Bristol-Myers Squibb BMY Stock Holding History

Bank of Nova Scotia’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.7M Sell
752,756
-50,416
-6% -$2.94M 0.08% 183
2025
Q4 		$43.3M Buy
803,172
+47,604
+6% +$2.29M 0.06% 221
2025
Q3 		$34.1M Buy
755,568
+223,196
+42% +$10.4M 0.06% 219
2025
Q2 		$24.6M Buy
532,372
+183,478
+53% +$9.01M 0.05% 236
2025
Q1 		$21.3M Sell
348,894
-232,856
-40% -$13.6M 0.05% 243
2024
Q4 		$32.9M Buy
581,750
+116,513
+25% +$6.51M 0.06% 221
2024
Q3 		$24.1M Sell
465,237
-91,938
-17% -$4.31M 0.05% 209
2024
Q2 		$23.1M Sell
557,175
-383,630
-41% -$17.2M 0.05% 244
2024
Q1 		$50.9M Sell
940,805
-449,526
-32% -$22.9M 0.1% 154
2023
Q4 		$71.3M Buy
1,390,331
+1,181,361
+565% +$62M 0.13% 129
2023
Q3 		$12.1M Buy
208,970
+25,153
+14% +$1.54M 0.03% 292
2023
Q2 		$11.8M Buy
183,817
+27,652
+18% +$1.85M 0.03% 263
2023
Q1 		$10.8M Sell
156,165
-49,369
-24% -$3.48M 0.03% 273
2022
Q4 		$14.8M Buy
205,534
+4,048
+2% +$305K 0.04% 283
2022
Q3 		$14.3M Sell
201,486
-694,067
-78% -$50.3M 0.05% 264
2022
Q2 		$69M Buy
895,553
+578,967
+183% +$44.1M 0.16% 111
2022
Q1 		$23.1M Sell
316,586
-1,363,989
-81% -$91.6M 0.04% 320
2021
Q4 		$105M Buy
1,680,575
+934,170
+125% +$54.8M 0.15% 147
2021
Q3 		$44.2M Buy
746,405
+377,594
+102% +$24.9M 0.08% 226
2021
Q2 		$24.6M Sell
368,811
-159,660
-30% -$10.4M 0.05% 286
2021
Q1 		$33.4M Sell
528,471
-934,547
-64% -$58.1M 0.07% 224
2020
Q4 		$90.8M Sell
1,463,018
-853,572
-37% -$52.5M 0.19% 107
2020
Q3 		$140M Sell
2,316,590
-915,385
-28% -$55.1M 0.38% 66
2020
Q2 		$190M Buy
3,231,975
+1,569,726
+94% +$93.9M 0.66% 36
2020
Q1 		$92.7M Sell
1,662,249
-205,166
-11% -$12.5M 0.32% 77
2019
Q4 		$120M Buy
1,867,415
+1,053,328
+129% +$60.3M 0.29% 84
2019
Q3 		$41.3M Buy
814,087
+61,433
+8% +$2.89M 0.12% 154
2019
Q2 		$33.8M Buy
752,654
+35,895
+5% +$1.67M 0.14% 147
2019
Q1 		$34.2M Sell
716,759
-532,764
-43% -$26.5M 0.14% 156
2018
Q4 		$64.9M Buy
1,249,523
+218,006
+21% +$11.7M 0.3% 79
2018
Q3 		$64M Buy
1,031,517
+845,831
+456% +$50.2M 0.28% 73
2018
Q2 		$10.3M Sell
185,686
-384,009
-67% -$20.7M 0.06% 249
2018
Q1 		$36M Sell
569,695
-329,953
-37% -$21.2M 0.19% 114
2017
Q4 		$55.1M Buy
899,648
+156,585
+21% +$9.79M 0.25% 94
2017
Q3 		$47.4M Sell
743,063
-157,416
-17% -$9.19M 0.28% 89
2017
Q2 		$50.2M Sell
900,479
-34,447
-4% -$1.87M 0.26% 79
2017
Q1 		$50.8M Buy
934,926
+341,702
+58% +$18.7M 0.22% 93
2016
Q4 		$34.7M Buy
593,224
+555,417
+1,469% +$30.4M 0.18% 78
2016
Q3 		$2.04M Buy
37,807
+477
+1% +$30.6K 0.01% 317
2016
Q2 		$2.75M Sell
37,330
-10,945
-23% -$773K 0.02% 261
2016
Q1 		$3.08M Sell
48,275
-490,305
-91% -$30.9M 0.02% 264
2015
Q4 		$37M Buy
538,580
+490,764
+1,026% +$32.4M 0.19% 77
2015
Q3 		$2.82M Buy
47,816
+7,481
+19% +$475K 0.02% 237
2015
Q2 		$2.68M Buy
40,335
+1,244
+3% +$82K 0.01% 210
2015
Q1 		$2.52M Buy
39,091
+10,837
+38% +$678K 0.01% 214
2014
Q4 		$1.67M Sell
28,254
-62,564
-69% -$3.53M 0.01% 241
2014
Q3 		$4.65M Buy
90,818
+64,225
+242% +$3.21M 0.02% 190
2014
Q2 		$1.29M Sell
26,593
-107,659
-80% -$5.31M 0.01% 261
2014
Q1 		$6.97M Sell
134,252
-43,463
-24% -$2.31M 0.03% 177
2013
Q4 		$9.45M Sell
177,715
-9,585
-5% -$488K 0.04% 171
2013
Q3 		$8.67M Sell
187,300
-38,036
-17% -$1.67M 0.04% 132
2013
Q2 		$10.1M Buy
+225,336
New +$9.78M 0.05% 135

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Nova Scotia's BMY Position: Q1 2026 in Review

Bank of Nova Scotia reduced its Bristol-Myers Squibb (BMY) stake by 6.3% in Q1 2026, selling an estimated $2.94M and leaving 752,756 shares worth $45.7M. The position accounts for 0.08% of the portfolio, ranked #183.

Bank of Nova Scotia first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $190M in Q2 2020. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Bank of Nova Scotia held 752,756 shares of Bristol-Myers Squibb worth $45.7M as of Q1 2026.
  • Bank of Nova Scotia sold 50,416 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.94M.
  • Bristol-Myers Squibb made up 0.08% of Bank of Nova Scotia's portfolio in Q1 2026, its #183 holding.
  • Bank of Nova Scotia first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Bank of Nova Scotia's Bristol-Myers Squibb position peaked at $190M in Q2 2020.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.